Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Hepatitis C

Free Subscription Articles published in Gut Retrieve available abstracts of 53 articles: HTML format

Single Articles

May 2008
1. JONES M , Owen JS
   How does interferon inhibit HCV cell entry?
   Gut. 2008;57:573-4.
   PubMed     Related articles   
   
   
   April 2008
2. PINZANI M , Arena U, Vizzutti F, Abraldes J, et al
   Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C.
   Gut. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. STARKEL P
   Genetic factors predicting response to interferon treatment for viral hepatitis C.
   Gut. 2008;57:440-2.
   PubMed     Related articles   
   
   
   March 2008
4. GOLDEN-MASON L , Madrigal-Estebas L, McGrath E, Conroy MJ, et al
   Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure.
   Gut. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. TARGHER G , Zoppini G, Muggeo M
   Differential relationships between basal and post-load insulin resistance indices and hepatic fibrosis in chronic hepatitis C and in non-alcoholic fatty liver disease.
   Gut. 2008;57:426.
   PubMed     Related articles   
   
   
   January 2008
6. RIGAMONTI C , Donato MF, Fraquelli M, Agnelli F, et al
   Transient elastography predicts fibrosis progression in patients with recurrent hepatitis c after liver transplantation.
   Gut. 2008;.
   PubMed     Related articles    Abstract available
   
   
   December 2007
7. KRAUS MR , Schafer A, Schottker K, Keicher C, et al
   Therapy of interferon-induced depression in chronic hepatitis C with citalopram: A randomized, double-blind, placebo-controlled study.
   Gut. 2007;.
   PubMed     Related articles    Abstract available   Free Full Text
   
   
   
8. POUPON R , Serfaty L
   Ursodeoxycholic acid in chronic hepatitis C.
   Gut. 2007;56:1652-3.
   PubMed     Related articles   
   
   
   November 2007
9. MURAO K , Imachi H, Yu X, Cao WM, et al
   Interferon-{alpha} decreases expression of human scavenger receptor class BI, possible HCV receptor in hepatocytes.
   Gut. 2007;.
   PubMed     Related articles    Abstract available
   
   
   September 2007
10. ASSELAH T , Bieche I, Narguet S, Sabbagh A, et al
    Liver Gene Expression Signature to Predict Response to Pegylated interferon plus Ribavirin combination therapy in Patients with Chronic Hepatitis C.
    Gut. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
11. PERSICO M , Capasso M, Russo R, Persico E, et al
    Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C.
    Gut. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
12. LIU CH , Liang CC, Lin JW, Chen SI, et al
    Pegylated Interferon Alfa-2a versus Standard Interferon Alfa-2a for Treatment-Naive Dialysis Patients with Chronic Hepatitis C: A Randomized Study.
    Gut. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
13. OBEN JA , Paulon E
    Fatty liver in chronic hepatitis C infection: unravelling the mechanisms.
    Gut. 2007;56:1186-8.
    PubMed     Related articles   
    
    
    August 2007
14. DAHABA AA , Worm HC, Zhu SM, Bao FP, et al
    Sensitivity and specificity of bispectral index for classification of overt hepatic encephalopathy. A multicentre, observer-blinded, validation study.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
15. DAI CY , Huang JF, Hsieh MY, Lee LP, et al
    Links between triglyceride levels, hepatitis C virus infection and diabetes.
    Gut. 2007;56:1167-8.
    PubMed     Related articles   
    
    
    
16. RYDER S
    Do high lipids help clearance of hepatitis C?
    Gut. 2007;56:1044-5.
    PubMed     Related articles   
    
    
    July 2007
17. CHAKASS D , Philippe D, Erdual E, Dharancy S, et al
    micro-Opioid receptor activation prevents acute hepatic inflammation and cell death.
    Gut. 2007;56:974-81.
    PubMed     Related articles    Abstract available
    
    
    
18. FRAQUELLI M , Rigamonti C, Casazza G, Conte D, et al
    Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease.
    Gut. 2007;56:968-73.
    PubMed     Related articles    Abstract available
    
    
    June 2007
19. OMATA M , Yoshida H, Toyota J, Tomita E, et al
    A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C.
    Gut. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
20. STROFFOLINI T , Rapicetta M, Di Stefano R, Bakr I, et al
    Hepatitis C virus clearance and gender * Authors' response.
    Gut. 2007;56:884.
    PubMed     Related articles   
    
    
    May 2007
21. KUMADA T , Toyoda H, Kiriyama S, Sone Y, et al
    Relation between incidence of hepatic carcinogenesis and integration value of alanine aminotransferase in patients with hepatitis C virus infection.
    Gut. 2007;56:738-9.
    PubMed     Related articles   
    
    
    
22. DAI CY , Huang JF, Hsieh MY, Lee LP, et al
    The role of gender on clearance of hepatitis C virus: a different story in an area endemic for hepatitis B and C.
    Gut. 2007;56:737-8.
    PubMed     Related articles   
    
    
    
23. THURSZ M
    Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection.
    Gut. 2007;56:613-614.
    PubMed     Related articles   
    
    
    March 2007
24. SVEGLIATI-BARONI G , Bugianesi E, Bousheral T, Ridolfi F, et al
    Post-load insulin resistance is an independent predictor of hepatic fibrosis in Virus C Chronic Hepatitis and in Nonalcoholic Fatty Liver Disease.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
25. PAYAN C , Pivert A, Morand P, Fafi-Kremer S, et al
    Rapid and early virological response to chronic Hepatitis C treatment with IFN alpha-2b or PEG- IFN alpha-2b plus ribavirin in HIV/HCV co-infected patients.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
26. EL-ZAYADI AR , Attia ME, Barakat EM, Zalata K, et al
    Non-alcoholic fatty liver disease in hcv-genotype 4 patients.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
27. NEAL K , Irving WL
    Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    February 2007
28. WATSON J , Graves S, Ferguson J, D'Este C, et al
    Hepatitis C virus RNA quantitation and degradation studies in whole blood samples in vitro.
    Gut. 2007;56:306-7.
    PubMed     Related articles   
    
    
    January 2007
29. HOURIOUX C , Patient R, Morin A, Blanchard E, et al
    The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    December 2006
30. CHOLONGITAS E , Quaglia A, Samonakis D, Senzolo M, et al
    Transjugular liver biopsy: how good is it for accurate histological interpretation?
    Gut. 2006;55:1789-94.
    PubMed     Related articles    Abstract available
    
    
    November 2006
31. SARTORI M , Andorno S, Pagliarulo M, Rigamonti C, et al
    Heterozygous {beta} -globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis c.
    Gut. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
32. FORTON DM
    Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition?
    Gut. 2006;55:1535-1537.
    PubMed     Related articles   
    
    
    
33. WATANABE T , Inoue M, Harada K, Homma N, et al
    A case of exacerbation of ulcerative colitis induced by combination therapy with PEG-interferon {alpha}-2b and ribavirin.
    Gut. 2006;55:1682-3.
    PubMed     Related articles   
    
    
    
34. COBBOLD JF , Wylezinska M, Cunningham C, Crossey ME, et al
    Non-invasive evaluation of hepatic fibrosis using magnetic resonance and ultrasound techniques * Author's reply.
    Gut. 2006;55:1670.
    PubMed     Related articles   
    
    
    
35. ARMENDARIZ-BORUNDA J , Islas-Carbajal MC, Meza-Garcia E, Rincon AR, et al
    A pilot study in patients with established advanced liver fibrosis using pirfenidone.
    Gut. 2006;55:1663-5.
    PubMed     Related articles   
    
    
    October 2006
36. CUA IH , Kwan V, Henriquez M, Kench J, et al
    Long term suppressive therapy with pegylated interferon for chronic hepatitis C associated membranoproliferative glomerulonephritis.
    Gut. 2006;55:1521-2.
    PubMed     Related articles       Free Full Text
    
    
    September 2006
37. BUTT AA , Justice AC, Skanderson M, Rigsby M, et al
    Rate and predictors of treatment prescription for hepatitis C.
    Gut. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
38. CODES L , Asselah T, Cazals-Hatem D, Tubach F, et al
    Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of menopause and steatosis and the potential benefit of hormone replacement therapy.
    Gut. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
39. MARZOUK D , Sass J, Bakr I, El Hoseiny M, et al
    Metabolic liver disease and HCV infection in rural Egypt.
    Gut. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
40. YU ML , Dai CY, Huang JF, Hou NJ, et al
    A randomised study of peginterferon and ribavirin for 16 vs 24 weeks in patients with genotype 2 chronic hepatitis C.
    Gut. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
41. PERRELLA A , Vitiello L, Atripaldi L, Conti P, et al
    Elevated CD4+/CD25+ T cell frequency and function during acute hepatitis C presage chronic evolution.
    Gut. 2006;55:1370-1.
    PubMed     Related articles   
    
    
    
42. DUDLEY T , O'donnell K, Haydon G, Mutimer D, et al
    Disappointing results of combination therapy for HCV?
    Gut. 2006;55:1362-3.
    PubMed     Related articles   
    
    
    
43. MANNS MP , Wedemeyer H, Cornberg M
    Treating viral hepatitis C: efficacy, side effects, and complications.
    Gut. 2006;55:1350-9.
    PubMed     Related articles   
    
    
    August 2006
44. IRVING WL
    Acute hepatitis C virus infection: a neglected disease?
    Gut. 2006;55:1075-1077.
    PubMed     Related articles   
    
    
    July 2006
45. MORENO-OTERO R , Trapero-Marugan M, Mendoza J
    Liver fibrosis assessment by transient elastography in hepatitis C patients with normal alanine aminotransferase.
    Gut. 2006;55:1055-6.
    PubMed     Related articles   
    
    
    
46. GUIDI M , Muratori P, Granito A, Muratori L, et al
    Steatosis in chronic hepatitis C * Authors' reply.
    Gut. 2006;55:1047-8.
    PubMed     Related articles   
    
    
    
47. KLENERMAN P , Semmo N
    Cellular immune responses against persistent hepatitis C virus: gone but not forgotten.
    Gut. 2006;55:914-6.
    PubMed     Related articles   
    
    
    June 2006
48. BERARDI S , Lodato F, Gramenzi A, D'Errico A, et al
    High incidence of allograft dysfunction in liver transplant patients treated with Peg-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?
    Gut. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
49. CAPRA F , Nicolini N, Franchini M
    Is the periodic repetition of a coagulation check necessary during anti-hepatitis C virus therapy?
    Gut. 2006;55:902.
    PubMed     Related articles   
    
    
    May 2006
50. SHERMAN M , Yoshida EM, Deschenes M, Krajden M, et al
    Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy.
    Gut. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
51. WEISSENBORN K , Ennen JC, Bokemeyer M, Ahl B, et al
    Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment.
    Gut. 2006;.
    PubMed     Related articles    Abstract available
    
    
    March 2006
52. SATO Y , Kato J, Takimoto R, Takada K, et al
    Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor-{alpha} expression via activation of NF-{kappa}B.
    Gut. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
53. HARCOURT G , Gomperts E, Donfield S, Klenerman P, et al
    Profound loss of HCV-specific interferon-gamma secreting CD4+ T cells in HIV/HCV co-infected patients.
    Gut. 2006;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: